Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07538544 · ClinicalTrials.gov registry record · Early Phase 1
MCE Molecular Imaging for ICI Myocarditis
A Early Phase 1 study, sponsored by University of Virginia.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
NCT07538544 is a Early Phase 1 study that has not yet begun recruiting, run by University of Virginia. The registered enrollment target is 30 participants.
The verdict
NCT07538544, a Early Phase 1 study, has not yet begun recruiting, sponsored by University of Virginia.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
Inflammation of the heart (myocarditis) is a serious condition that can cause heart failure, abnormal heart rhythms, cardiac arrest, and death. A new class of medications used for cancer called immune checkpoint inhibitors (ICI) work by increasing the body's inflammmation response, but can have a side effect of causing inflammation of the heart (ICI myocarditis). Rapid diagnosis of this condition is key to reversing it. The purpose of this study is to determine whether ICI myocarditis can be diagnosed using a new form of ultrasound imaging of the heart (echocardiography) that uses a contrast agent that is targeted to inflammation (Sonazoid).
Interventions
- DIAGNOSTIC_TEST Myocardial contrast echocardiography molecular imaging for inflammation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2030-07-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07538544
The ClinicalTrials.gov registry entry for NCT07538544 describes a study currently listed as not yet recruiting, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Myocardial contrast echocardiography molecular imaging for inflammation is the first listed.
NCT07538544 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07538544 about?
NCT07538544 is a clinical study titled "MCE Molecular Imaging for ICI Myocarditis". Inflammation of the heart (myocarditis) is a serious condition that can cause heart failure, abnormal heart rhythms, cardiac arrest, and death. A new class of medications used for cancer called immune checkpoint inhibitors (ICI) work by increasing the body's inflammmation response, but can have a si...
What is the current status of trial NCT07538544?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2026-07-01. Estimated completion is 2030-07-01.
What interventions are being tested in trial NCT07538544?
The interventions under investigation include: Myocardial contrast echocardiography molecular imaging for inflammation (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07538544?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.